Norway

The Norwegian Gastrointestinal Association will host a hybrid patient seminar (in-person and online) on 19 May, focusing on current and future IBD treatment options.
The programme includes a lecture by a professor and gastroenterologist from Oslo University Hospital, followed by presentations from health authorities and the pharmaceutical industry on the national tender system for accessing new medicines.

The Association will also present results from a patient survey on experiences with this system.
The event will conclude with a panel discussion titled “Are patients’ concerns about the tender system unfounded, or is the system ripe for revision?”

In Norway, biological treatment is selected based on which preparation wins the annual tender. This means that patients must switch treatment within the same biological category to the option that offers the lowest price.

More information:

https://magetarm.no/